Income Statement (TTM)
Parenteral Drugs (India) Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
|
|---|---|---|---|---|---|---|---|
| Revenue | 234 | 182 | 122 | 122 | 99 | 93 | 85 |
| Change (%) | -22.25 | -33.05 | 0.10 | -18.81 | -6.02 | -8.57 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 67 | 59 | 59 | 64 | 50 | 52 | 55 |
| Change (%) | -11.72 | -0.59 | 8.62 | -22.01 | 4.17 | 5.70 | |
| % of Revenue | 28.56 | 32.43 | 48.16 | 52.26 | 50.20 | 55.64 | 64.33 |
| Gross Operating Profit | 167 | 123 | 63 | 58 | 49 | 41 | 30 |
| Change (%) | -26.46 | -48.64 | -7.82 | -15.31 | -16.29 | -26.48 | |
| % of Revenue | 71.44 | 67.57 | 51.84 | 47.74 | 49.80 | 44.36 | 35.67 |
| SG&A | 196 | 186 | 146 | 138 | 127 | 126 | 148 |
| Change (%) | -5.21 | -21.37 | -5.37 | -8.15 | -0.41 | 16.96 | |
| % of Revenue | 83.83 | 102.20 | 120.03 | 113.48 | 128.38 | 136.04 | 174.04 |
| R&D | |||||||
| Change (%) | |||||||
| % of Revenue | |||||||
| OpEx | 601 | 548 | 413 | 381 | 326 | 323 | 637 |
| Change (%) | -8.83 | -24.63 | -7.72 | -14.43 | -0.75 | 96.83 | |
| % of Revenue | 256.91 | 301.26 | 339.15 | 312.67 | 329.56 | 348.03 | 749.25 |
| Operating Income | -367 | -366 | -291 | -259 | -227 | -230 | -552 |
| Change (%) | -0.27 | -20.45 | -10.99 | -12.36 | 1.54 | 139.32 | |
| % of Revenue | -156.91 | -201.26 | -239.15 | -212.67 | -229.56 | -248.03 | -649.25 |
| Interest Expense | -1,177 | -1,217 | -1,254 | -1,297 | -1,341 | -1,387 | -1,062 |
| Change (%) | 3.41 | 3.08 | 3.39 | 3.42 | 3.42 | -23.40 | |
| % of Revenue | -503.43 | -669.55 | -1,030.89 | -1,064.78 | -1,356.29 | -1,492.54 | -1,250.51 |
| Net Income | -1,240 | -1,288 | -1,217 | -1,215 | -1,215 | -1,250 | -764 |
| Change (%) | 3.90 | -5.50 | -0.15 | -0.05 | 2.92 | -38.92 | |
| % of Revenue | -530.31 | -708.68 | -1,000.31 | -997.86 | -1,228.44 | -1,345.30 | -898.77 |
Source: Capital IQ
